Study identification

PURI

https://redirect.ema.europa.eu/resource/28228

EU PAS number

EUPAS7727

Study ID

28228

Official title and acronym

Randomised Controlled Trial (RCT) vs Real Life initiative (RCT vs Real Life)

DARWIN EU® study

No

Study countries

United Kingdom

Study description

To determine the proportion of patients with COPD in the community who would meet inclusion/exclusion criteria of recently registered RCTs of long-acting bronchodilator therapy and to compare characteristics of COPD patients in OPCRD with those from individual RCTs

Study status

Finalised
Research institutions and networks

Institutions

Contact details

David Price

Primary lead investigator
Study timelines

Date when funding contract was signed

Actual:

Study start date

Planned:
Actual:

Data analysis start date

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Pharmaceutical company and other private sector 

More details on funding

Boehringer Ingelheim
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable